|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hildesheim A and Wang SS: Host and viral
genetics and risk of cervical cancer: A review. Virus Res.
89:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Engels BM and Hutvagner G: Principles and
effects of microRNA-mediated posttranscriptional gene regulation.
Oncogene. 25:6163–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davidson B, Tropé CG and Reich R: The
clinical and diagnostic role of microRNAs in ovarian carcinoma.
Gynecol Oncol. 133:640–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seven M, Karatas OF, Duz MB and Ozen M:
The role of miRNAs in cancer: From pathogenesis to therapeutic
implications. Future Oncol. 10:1027–1048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Yin Y, Hu Y, Zhang J, Bian Z,
Song M, Hua D and Huang Z: MicroRNA-204-5p inhibits gastric cancer
cell proliferation by downregulating USP47 and RAB22A. Med Oncol.
32:3312015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li W, Jin X, Zhang Q, Zhang G, Deng X and
Ma L: Decreased expression of miR-204 is associated with poor
prognosis in patients with breast cancer. Int J Clin Exp Pathol.
7:3287–3292. 2014.PubMed/NCBI
|
|
12
|
Munari E, Marchionni L, Chitre A, Hayashi
M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO
and Netto GJ: Clear cell papillary renal cell carcinoma: micro-RNA
expression profiling and comparison with clear cell renal cell
carcinoma and papillary renal cell carcinoma. Hum Pathol.
45:1130–1138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi L, Zhang B, Sun X, Lu S, Liu Z, Liu Y,
Li H, Wang L, Wang X and Zhao C: MiR-204 inhibits human NSCLC
metastasis through suppression of NUAK1. Br J Cancer.
111:2316–2327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Imam JS, Plyler JR, Bansal H, Prajapati S,
Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, et
al: Genomic loss of tumor suppressor miRNA-204 promotes cancer cell
migration and invasion by activating AKT/mTOR/Rac1 signaling and
actin reorganization. PLoS One. 7:e523972012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu X, Zeng Y, Wu S, Zhong J, Wang Y and Xu
J: MiR-204, down-regulated in retinoblastoma, regulates
proliferation and invasion of human retinoblastoma cells by
targeting CyclinD2 and MMP-9. FEBS Lett. 589:645–650. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li G, Luna C, Qiu J, Epstein DL and
Gonzalez P: Role of miR-204 in the regulation of apoptosis,
endoplasmic reticulum stress response, and inflammation in human
trabecular meshwork cells. Invest Ophthalmol Vis Sci. 52:2999–3007.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
22
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee CC, Chen WS, Chen CC, Chen LL, Lin YS,
Fan CS and Huang TS: TCF12 protein functions as transcriptional
repressor of E-cadherin, and its overexpression is correlated with
metastasis of colorectal cancer. J Biol Chem. 287:2798–2809. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen WS, Chen CC, Chen LL, Lee CC and
Huang TS: Secreted heat shock protein 90α (HSP90α) induces nuclear
factor-κB-mediated TCF12 protein expression to down-regulate
E-cadherin and to enhance colorectal cancer cell migration and
invasion. J Biol Chem. 288:9001–9010. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bao W, Wang HH, Tian FJ, He XY, Qiu MT,
Wang JY, Zhang HJ, Wang LH and Wan XP: A TrkB-STAT3-miR-204-5p
regulatory circuitry controls proliferation and invasion of
endometrial carcinoma cells. Mol Cancer. 12:1552013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma L, Deng X, Wu M, Zhang G and Huang J:
Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and
facilitates invasion of EBV-associated nasopharyngeal carcinoma
cells. FEBS Lett. 588:1562–1570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ryan J, Tivnan A, Fay J, Bryan K, Meehan
M, Creevey L, Lynch J, Bray IM, O'Meara A, Tracey L, et al:
MicroRNA-204 increases sensitivity of neuroblastoma cells to
cisplatin and is associated with a favourable clinical outcome. Br
J Cancer. 107:967–976. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou X, Li L, Su J and Zhang G: Decreased
miR-204 in H. pylori-associated gastric cancer promotes cancer cell
proliferation and invasion by targeting SOX4. PLoS One.
9:e1014572014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu YH, Wei YP, Shen NJ, Wang ZC, Kan T,
Yu WL, Yi B and Zhang YJ: miR-204 inhibits epithelial to
mesenchymal transition by targeting slug in intrahepatic
cholangiocarcinoma cells. Cell Physiol Biochem. 32:1331–1341. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang L, Wang X and Chen P: MiR-204 down
regulates SIRT1 and reverts SIRT1-induced epithelial mesenchymal
transition, anoikis resistance and invasion in gastric cancer
cells. BMC Cancer. 13:2902013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu L, Wang J, Li X, Ma J, Shi C, Zhu H,
Xi Q, Zhang J, Zhao X and Gu M: miR-204-5p suppresses cell
proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Biochem Biophys Res Commun. 457:621–626. 2015. View Article : Google Scholar : PubMed/NCBI
|
